What is NDC 68462-730?

68462-730 is the product NDC for Sodium Phosphates, Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL injection, solution, listed with the FDA by GLENMARK PHARMACEUTICALS INC., USA. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Heptahydrate.

GLENMARK PHARMACEUTICALS INC., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Phosphates?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Phosphates NDC 68462-730 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-730Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0730Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-730-25	68462073025	25 VIAL, SINGLE-DOSE in 1 CARTON (68462-730-25) / 50 mL in 1 VIAL, SINGLE-DOSE (68462-730-50)Marketed from Feb 23, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Phosphates
Generic name (nonproprietary): sodium phosphates
Active ingredients: Sodium phosphate, Monobasic, Monohydrate — 276 mg/mLSodium phosphate, Dibasic, Heptahydrate — 268 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: GLENMARK PHARMACEUTICALS INC., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220683
Marketing start: Feb 23, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 68462-730_c968f70b-a670-4aef-a7e0-89468ad62d9cSPL ID c968f70b-a670-4aef-a7e0-89468ad62d9cSPL set ID c968f70b-a670-4aef-a7e0-89468ad62d9cRxCUI 1872384, 1872443, 1872447UNII 593YOG76RN, 70WT22SF4BUPC 0368462730256, 0368462729151, 0368462728055, 0368462728253, 0368462729250

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468462073025 followed by a unit qualifier and the quantity

Package 68462-0730-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 12, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium phosphates injection, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (Na + 4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68462-730

What is NDC 68462-730?: 68462-730 is the product NDC for Sodium Phosphates, Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL injection, solution, listed with the FDA by GLENMARK PHARMACEUTICALS INC., USA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Phosphates.
What is the active ingredient?: Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Heptahydrate.
Who is the labeler?: GLENMARK PHARMACEUTICALS INC., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Phosphates?: 14 other product NDCs are listed under this name. See all Sodium Phosphates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Phosphates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-200	65145-0200-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-201	65145-0201-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-202	65145-0202-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-728	68462-0728-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-729	68462-0729-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	Civica, Inc.	72572-309	72572-0309-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7350	00517-7350-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7305	00517-7305-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7315	00517-7315-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-881	63323-0881-16

All 15 Sodium Phosphates NDCs

Other NDCs under ANDA 220683

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220683
Product	Strength	Form · route	Labeler	Product NDC
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-728
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-729
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-202
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-200
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-201